Long-acting B-agonist (LABA) monotherapy among patients with asthma is rare. Of those with continued LABA monotherapy, most had missed opportunities for therapy change or education.

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

Beta2 (ß2)-agonist medications are a type of inhaled bronchodilator used to treat asthma. In the pathophysiology of asthma, tightened airways cause wheezing, chest tightness, shortness of breath ...

Low-intensity, High-yield Early Intervention Measures. The first intervention should be a beta-2 agonist delivered promptly by an age-appropriate inhalational device (Fig. 2).

Ye X, Gutierrez B, Zarotsky V, et al. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured ...

Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the disease burden.

ICS combined with short-acting β agonists and ICS combined with the long-acting β agonist formoterol are each associated with reduced asthma exacerbations compared with SABA alone.

Article Reference: Sushrut D Shah, Christoffer Lind, Francesco De Pascali, Raymond B Penn, Alexander D MacKerell Jr., Deepak A Deshpande, “In silico identification of a β2-adrenoceptor ...

Iam a 27 yr old female and I am currently on salbutamol inhaler. I try to work out everyday but I am concerned about the .effects of this drug on my heart long term. Am I not going to have some ...